Detection and identification of tumor‐associated protein variants in human hepatocellular carcinomas
暂无分享,去创建一个
S. Chung | P. Jungblut | E. Zeindl-Eberhart | S. Haraida | S. Liebmann | S. Lamer | D. Mayer | Gundula Jäger | H. Rabes | E. Zeindl‐Eberhart
[1] S. Tsuchida,et al. Glutathione transferases and cancer. , 1992, Critical reviews in biochemistry and molecular biology.
[2] H. Rabes,et al. Expression of tumor‐associated protein variants in chemically induced rat hepatomas and transformed rat liver cell lines determined by two‐dimensional electrophoresis , 1994, Electrophoresis.
[3] A. Otto,et al. Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. , 1994, The Journal of biological chemistry.
[4] S. Hanash,et al. Disease proteomics , 2003, Nature.
[5] C. Ling,et al. Isolation of differentially expressed aldose reductase in ovaries after estrogen withdrawal from hypophysectomized diethylstilbestrol treated rats: increased expression during apoptosis , 2000, Molecular and Cellular Endocrinology.
[6] T. Benjamin,et al. Micropreparative immobilized pH gradient two‐dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins , 1995, Electrophoresis.
[7] P. Jungblut,et al. A new method to assign immunodetected spots in the complex two‐dimensional electrophoresis pattern , 1997, Electrophoresis.
[8] Hoguen Kim,et al. Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma , 2002, International journal of cancer.
[9] D. Harrison,et al. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. , 1999, The Biochemical journal.
[10] R. Zeng,et al. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two‐dimensional electrophoresis and liquidchromatography‐ion trap mass spectrometry , 2000 .
[11] P. Jungblut,et al. Matrix-assisted laser desorption-ionization mass spectrometry peptide mass fingerprinting for proteome analysis: identification efficiency after on-blot or in-gel digestion with and without desalting procedures. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[12] R. Gani,et al. Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases. , 2000, The Kobe journal of medical sciences.
[13] H. Lee,et al. Nuclear matrix of calreticulin in hepatocellular carcinoma. , 2000, Cancer research.
[14] F. X. Bosch,et al. Policy forum: public health. Reducing liver cancer--global control of aflatoxin. , 1999, Science.
[15] E. Maser,et al. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. , 1995, Biochemical pharmacology.
[16] M. Chung,et al. Proteome database of hepatocellular carcinoma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] N. Anderson,et al. Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusing. , 1978, Analytical biochemistry.
[18] H. Jörnvall,et al. Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Jungblut,et al. Proteome analysis of rat hepatomas: Carcinogen‐dependent tumor‐associated protein variants , 2001, Electrophoresis.
[20] J. Klose,et al. Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. , 1999, Methods in molecular biology.
[21] M McCarthy,et al. Hepatology , 1999, Rapid Medicine.
[22] Maxey C M Chung,et al. Hepatocellular carcinoma: From bedside to proteomics , 2001, Proteomics.
[23] T. Flynn,et al. A new nomenclature for the aldo-keto reductase superfamily. , 1997, Biochemical pharmacology.
[24] Laura Beretta,et al. A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis* , 2002, Molecular & Cellular Proteomics.
[25] T. Flynn,et al. The aldo-keto reductases and their role in cancer. , 1999, Advances in experimental medicine and biology.
[26] L. Qin,et al. The prognostic molecular markers in hepatocellular carcinoma. , 2002, World journal of gastroenterology.
[27] Julia Martin,et al. Pattern , 2005, The Fairchild Books Dictionary of Fashion.
[28] S. Chung,et al. Overexpression of aldose reductase in liver cancers may contribute to drug resistance , 2001, Anti-cancer drugs.
[29] O. Hayaishi,et al. A superfamily of NADPH-dependent reductases in eukaryotes and prokaryotes. , 1989, Experimental eye research.
[30] B. Maleeff,et al. Two‐dimensional electrophoresis of liver proteins: Characterization of a drug‐induced hepatomegaly in rats , 2000 .
[31] M. Schwab,et al. Cloning of the human aflatoxin B1-aldehyde reductase gene at 1p35-1p36.1 in a region frequently altered in human tumor cells. , 1998, Cancer research.
[32] Joachim Klose,et al. Two‐dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome , 1995, Electrophoresis.
[33] F. X. Bosch,et al. Reducing Liver Cancer--Global Control of Aflatoxin , 1999, Science.
[34] Sheung Tat Fan,et al. Identification and Characterization of a Novel Human Aldose Reductase-like Gene* , 1998, The Journal of Biological Chemistry.
[35] S. Hanash. Disease proteomics : Proteomics , 2003 .
[36] G. Auer,et al. Cancer proteomics: From identification of novel markers to creation of artifical learning models for tumor classification , 2000, Electrophoresis.
[37] P. Wirth. Two‐dimensional polyacrylamide gel electrophoresis in experimental hepatocarcinogenesis studies , 1994, Electrophoresis.
[38] E. Ren,et al. Two‐dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC‐M, and identification of the separated proteins by mass spectrometry , 2000, Electrophoresis.
[39] P. Bannasch. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. , 1996, Progress in liver diseases.
[40] D. Greene,et al. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells. , 1993, The American journal of physiology.
[41] H. Rabes,et al. Variant protein patterns in hepatomas and transformed liver cell lines as determined by high resolution two-dimensional gel electrophoresis (2DE). , 1992, Carcinogenesis.
[42] N. Taniguchi,et al. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: Implication in detoxification of cytotoxic aldehydes , 1995, International journal of cancer.
[43] A. Otto,et al. Further characterization of a rat hepatoma-derived aldose-reductase-like protein--organ distribution and modulation in vitro. , 1997, European journal of biochemistry.
[44] W. Anderson,et al. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma , 1998, Hepatology.
[45] R. Zeng,et al. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. , 2000, Electrophoresis.
[46] T. Flynn,et al. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. , 1998, Biochimica et biophysica acta.
[47] P. Shapiro,et al. Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases , 2002, Anti-cancer drugs.
[48] J. Hayes,et al. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] Sung Gyoo Park,et al. Proteome analysis of hepatocellular carcinoma. , 2002, Biochemical and biophysical research communications.
[50] R. Seifert,et al. Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. , 1990, Journal of biochemical and biophysical methods.
[51] P. Kador,et al. The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis). , 2001, Chemico-biological interactions.
[52] Jung Eun Shim,et al. An integrated proteome database for two‐dimensional electrophoresis data analysis and laboratory information management system , 2002, Proteomics.
[53] N G Anderson,et al. Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. , 1978, Analytical biochemistry.
[54] Nam-Gyun Kim,et al. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma , 2002, Hepatology.
[55] N. Anderson,et al. Analytical techniques for cell fractions , 1969 .
[56] L. Schwartz,et al. Two-dimensional electrophoresis of liver proteins: characterization of a drug-induced hepatomegaly in rats. , 2000, Electrophoresis.